Skip to main content
OpenTrials

Clinical trial condition

Stargardt Macular Dystrophy

Explore clinical trials studying Stargardt Macular Dystrophy. Study availability and eligibility vary by location and protocol.

7 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Stargardt Macular Dystrophy trial results

Recruiting

A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions

NCT07734064

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +7 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • Cincinnati Eye Institute Cincinnati, Ohio, United States
  • Retina Foundation of Southwest Dallas, Texas, United States
View Trial Details
Recruiting

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

NCT07425574

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +7 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • University of California Health - UC Davis Sacramento, California, United States
  • University of Illinois Chicago - UI Health Chicago, Illinois, United States
View all 15 locations
View Trial Details
Recruiting

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

NCT06942572

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +7 more
Locations
  • UCHealth Sue Anschutz-Rodgers Eye Center, Aurora, Colorado, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
  • Massachusetts Eye and Ear Infirmary Boston, Massachusetts, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Active, not recruiting

Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease

NCT02402660

Conditions
Autosomal Recessive Stargardt Disease 1 (ABCA4-related), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +8 more
Locations
  • Alkeus Site Phoenix, Arizona, United States
  • Alkeus Site Los Angeles, California, United States
  • Alkeus Site Aurora, Colorado, United States
  • Alkeus Site Gainesville, Florida, United States
View all 14 locations
View Trial Details
Active, not recruiting

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

NCT04239625

Conditions
Autosomal Recessive Stargardt Disease 1 (ABCA4-related), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +8 more
Locations
  • Alkeus Site Phoenix, Arizona, United States
  • Alkeus Site Los Angeles, California, United States
  • Alkeus Site Aurora, Colorado, United States
  • Alkeus Site Gainesville, Florida, United States
View Trial Details

Related conditions